Assignee
TOBIRA THERAPEUTICS INC
US·6 granted patents·17 pending applications·7 citations·filing 2008–2020
Top patents by PatentIndex Score
23 records- 0184US8362058B2Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2008·Granted Jan 29, 2013·5 cites·13 claims
- 0272US10407411B2Purified cenicriviroc and purified intermediates for making cenicrivirocTOBIRA THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·1 cites·16 claims
- 0371US10301287B2Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylateTOBIRA THERAPEUTICS INC·Filed 2017·Granted May 28, 2019·1 cites·44 claims
- 0470US2020297700A1Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0565US10045968B2Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2014·Granted Aug 14, 2018·0 cites·5 claims
- 0665US2019038604A1Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0765US2019343806A1Cenicriviroc for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0863US2021171504A1Purified cenicriviroc and purified intermediates for making cenicrivirocTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0962US2020368247A1Cenicriviroc for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1062US2020360347A1Cenicriviroc for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1157US2020268768A1Cenicriviroc combination therapy for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1256US2020095229A1Purified cenicriviroc and purified intermediates for making cenicrivirocTOBIRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1355US2018110754A1Cenicriviroc for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1454US2019099429A1Cenicriviroc for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1553US2018360846A1Cenicriviroc combination therapy for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1652US2020216476A1Process of making cenicriviroc and related analogsTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1751US2020000772A1Cenicriviroc combination therapy for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1850US9688666B2Lamivudine saltsTOBIRA THERAPEUTICS INC·Filed 2014·Granted Jun 27, 2017·0 cites·12 claims
- 1948US10526349B2Process of making cenicriviroc and related analogsTOBIRA THERAPEUTICS INC·Filed 2015·Granted Jan 7, 2020·0 cites·8 claims
- 2044US2017239262A1Cenicriviroc for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2142US2016081985A1Cenicriviroc compositions and methods of making and using the sameTOBIRA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2240US2017319548A1Cenicriviroc combination therapy for the treatment of fibrosisTOBIRA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2338US2017105969A1Cenicriviroc for the treatment of hiv-2 infectionTOBIRA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →